Page 3 - Immunology
Lipid Nanoparticles (LNP): The New Cargo for Drug Delivery
Explore how to optimize Lipid Nanoparticules (LNP) for mRNA delivery for druf development. This study highlights key formulation parameters: buffer composition, lipid selection; crucial for enhancing transfection
The Full TriLink Catalog Expertly Delivered by Tebubio
Looking for high-quality mRNA, nucleotides, and custom oligonucleotides?Tebubio delivers the complete TriLink catalogue, giving researchers easy access to industry-leading reagents.
Tebubio supports the Femmes & Sciences association to promote the role of women in science
Tebubio is proud to support the role of women in the world of scientific research by joining forces with the Femmes & Sciences association.
Unveiling the Next Generation of Actin Imaging
Advancing Live-Cell Actin Imaging with Spirochrome New Products
Actin cytoskeleton imaging is a cornerstone of cellular biology, playing a pivotal role in understanding cell motility, morphology, and
Discover Spirochrome’s Latest Fluorescent Probes: Transform Your Cell Imaging
As the complexity of cellular research grows, scientists need tools that are precise, versatile, and easy to use. To meet these demands, Spirochrome has expanded its portfolio with a series of innovative
Redefining Plasma Membrane Imaging: Discover the Power of PKmemâ„¢ Probes
Introducing PKmemâ„¢ Probes: Crossing Cellular Boundaries with Precision
In cellular research, precisely visualising the plasma membrane can unlock critical insights.Â
Revolutionising Research: The First Small-Molecule Probes to Specifically Label Peroxisomes
Streamlining Peroxisome Imaging: A New Era with Peroxi_SPY Probes
In the world of scientific research, the need for efficient and reliable tools is constant, particularly when it comes to live cell imaging
Unlocking the Next Frontier in Immuno-Oncology: Powering T and NK Cell Therapies with Nanotein’s Innovative Platforms
Powering T and NK Cell Therapies with Nanotein’s Innovative Platforms
In the ever-evolving field of immuno-oncology, the race to develop the most effective cell-based therapies has never been more urgent—or
Revolutionising mRNA Production: When Simplicity Meets Efficiency
mRNA-Based Therapeutics: Pioneering the Future of Medicine
Over the past few years, mRNA-based therapeutics have emerged as a promising approach to treat various diseases, including cancer, infectious
Optimising mRNA for Therapeutics: The Synergy of CleanCap Technology and Minimal UTRs
mRNA and UTRs: Unlocking New Frontiers in Therapeutic Innovation
Over the past five years, there has been an explosive surge in scientific interest surrounding messenger RNA (mRNA), as this small but
Virax Biolabs Announces Agreement with Tebubio to expand distribution of ImmuneSelect Across the European Union, Norway and Switzerland
Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced
Enhance Your Therapeutic mRNA Research Projects with Modified NTPs
How Modified NTPs are Revolutionising mRNA Vaccine Technology
In recent years, the spotlight on mRNA (messenger RNA) technology has intensified, largely due to its pivotal role in developing COVID-19 vaccines